Lack of association between mitochondrial DNA polymorphisms and didexoxynucleosideinduced hyperlactataemia in black-African, HIV-1-infected patients Results mtDNA was obtained from 40 cases and 38 controls. 82.5% of cases and 63.2% of the controls were female (P= 0.05). The ethnicity of the majority of participants were self-defined as Zulu or Sotho (80% of cases and 63% of controls; P=0.184) and all of them were exposed to either d4T (100% of cases and 87% of controls) or AZT (13% of controls). The median blood lactate level in cases at the time of diagnosis was 7.65 mmol/l (IQR 6.65-9.45). The distribution of mtDNA haplotypes was not different between cases and controls (P=0.137) neither were the predicted haplogroups (P=0.429). After adjusting for haplogroup distribution and ethnicity only factors known to be associated with HL, such as female gender (OR 5.92; ) and CD4 count <200 cell/ml (OR 4.02; 95%CI 1.03-15.68) remained independently associated with case status.
Conclusions
We did not find any association between mtDNA polymorphisms and the occurrence of HL in black African adults exposed to dideoxynucleosides. Contrary to what has been published on other mitochondrial toxicities, our data suggest that mtDNA variability may not explain any predisposition for dideoxynucleoside-associated HL.
